IE45801B1 - Crystalline potassium salt of -nicotinamide-adenine-dinucleotide-phosphoric acid - Google Patents
Crystalline potassium salt of -nicotinamide-adenine-dinucleotide-phosphoric acidInfo
- Publication number
- IE45801B1 IE45801B1 IE1891/77A IE189177A IE45801B1 IE 45801 B1 IE45801 B1 IE 45801B1 IE 1891/77 A IE1891/77 A IE 1891/77A IE 189177 A IE189177 A IE 189177A IE 45801 B1 IE45801 B1 IE 45801B1
- Authority
- IE
- Ireland
- Prior art keywords
- potassium salt
- phosphoric acid
- nicotinamide
- dinucleotide
- adenine
- Prior art date
Links
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 title claims abstract description 14
- 238000002425 crystallisation Methods 0.000 claims abstract description 18
- 239000013078 crystal Substances 0.000 claims abstract description 12
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 claims abstract description 10
- 239000003960 organic solvent Substances 0.000 claims abstract description 8
- 239000007864 aqueous solution Substances 0.000 claims abstract description 5
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 230000008025 crystallization Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 description 4
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 3
- 239000002274 desiccant Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 238000002447 crystallographic data Methods 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 1
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772704109 DE2704109A1 (de) | 1977-02-01 | 1977-02-01 | Kristallines kaliumsalz von beta-nicotinamid-adenindinucleotid- phosphorsaeure und verfahren zu seiner herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE45801L IE45801L (en) | 1978-08-01 |
| IE45801B1 true IE45801B1 (en) | 1982-12-01 |
Family
ID=6000081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1891/77A IE45801B1 (en) | 1977-02-01 | 1977-09-14 | Crystalline potassium salt of -nicotinamide-adenine-dinucleotide-phosphoric acid |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4151349A (enExample) |
| JP (1) | JPS5395995A (enExample) |
| DE (1) | DE2704109A1 (enExample) |
| GB (1) | GB1540783A (enExample) |
| IE (1) | IE45801B1 (enExample) |
| NL (1) | NL7800009A (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5767597A (en) * | 1980-10-15 | 1982-04-24 | Kohjin Co Ltd | Preparation of beta-nicotinamide-adenine-dinucleotide crystal |
| US4711955A (en) * | 1981-04-17 | 1987-12-08 | Yale University | Modified nucleotides and methods of preparing and using same |
| JP3081016B2 (ja) * | 1991-03-05 | 2000-08-28 | オリエンタル酵母工業株式会社 | 結晶性チオニコチンアミド−アデニンジヌクレオ チド燐酸カリウム塩及びその製造法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB930428A (en) * | 1961-08-02 | 1963-07-03 | Takeda Chemical Industries Ltd | A method for purification of 5-purine-nucleotides |
| DE1620555A1 (de) * | 1965-07-14 | 1970-04-16 | Takeda Chemical Industries Ltd | Verfahren zur Herstellung von 5'-Purinnucleotiden |
| GB1197758A (en) * | 1967-09-06 | 1970-07-08 | Dresden Arzneimittel | Process for the Preparation of the Tetrasodium Salt of Reduced Nicotinamide-Adenine-Dinucleotide-Phosphate. |
-
1977
- 1977-02-01 DE DE19772704109 patent/DE2704109A1/de active Granted
- 1977-09-14 IE IE1891/77A patent/IE45801B1/en not_active IP Right Cessation
- 1977-09-16 GB GB38719/77A patent/GB1540783A/en not_active Expired
- 1977-09-23 US US05/836,112 patent/US4151349A/en not_active Expired - Lifetime
- 1977-09-28 JP JP11655677A patent/JPS5395995A/ja active Granted
-
1978
- 1978-01-02 NL NL7800009A patent/NL7800009A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE45801L (en) | 1978-08-01 |
| JPS5527078B2 (enExample) | 1980-07-17 |
| GB1540783A (en) | 1979-02-14 |
| DE2704109C2 (enExample) | 1987-08-13 |
| JPS5395995A (en) | 1978-08-22 |
| NL7800009A (nl) | 1978-08-03 |
| DE2704109A1 (de) | 1978-08-10 |
| US4151349A (en) | 1979-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4822807A (en) | Pharmaceutical composition containing a stable modification of torasemide | |
| WO2020068705A1 (en) | Process of making calcium alpha-ketoglutarate | |
| EP3617191B9 (en) | Method for manufacturing diastereomer of citric acid derivative | |
| CZ112978A3 (en) | Process for preparing d,1,5-methyltetrahydrofolic acid or salts thereof being acceptable from pharmaceutical point of view | |
| US4515943A (en) | Crystal of beta-nicotinamide-adenine-dinucleotide and process for preparing the same | |
| US4151349A (en) | Crystalline potassium salt of β-nicotinamide adenine dinucleotide phosphoric acid and method for its preparation | |
| US5480982A (en) | Crystalline potassium salt of thinonicotinamide adenine dinucleotide phosphate | |
| US4148994A (en) | Crystalline metal salts of β-nicotinamide-adenine-dinucleotide | |
| JPWO2007083631A1 (ja) | Ｓ−アデノシル−ｌ−メチオニンの安定化法及び安定化された組成物 | |
| SU1726371A1 (ru) | Гидроселенит кобальта (п) дигидрат | |
| EP0007689B1 (en) | Production of sodium cephamandole derivatives | |
| CN102260291A (zh) | 一种核黄素磷酸钠晶体化合物、其药物组合物及制备方法 | |
| US2984661A (en) | Method of preparing pure vitamin b12 and intermediary obtained thereby | |
| JPS606958B2 (ja) | 抗生物質の精製法 | |
| Rowley et al. | Preparation and properties of calcium monofluorophosphate dihydrate | |
| US4124636A (en) | Method of preparing monopotassium L-malate and its monohydrate | |
| CN112480146B (zh) | 一种头孢呋辛酸混合溶剂化物、晶型及制备方法 | |
| US2891051A (en) | Adducts of salts of novobiocin | |
| JP3117949B2 (ja) | Ｌ−アスコルビン酸−２−リン酸ナトリウム塩の結晶 | |
| JPH02131494A (ja) | 結晶状ｌ−アスコルビン酸−２−リン酸ナトリウム塩の製造法 | |
| CN118666925A (zh) | 还原型β-烟酰胺单核苷酸一钠一镁盐晶型及其制备方法和应用 | |
| MASUDA et al. | ISOLATION AND IDENTIFICATION OF FLAVIN ADENINE DINUCLEOTIDE II STUDIES ON PURIFICATION | |
| IE45684B1 (en) | Crystallised potassium salt of adenosine5-5'-diphosphoric acid and process for its preparation | |
| JPS63233783A (ja) | 蘚苔植物の培養細胞の培養方法 | |
| JPH03170485A (ja) | 新規なオキサゾピロロキノリン化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |